The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410000, China
NCT Number: NCT05769855
The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Changsha, Hunan, 410000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HR18034 380mg
ropivacaine HCl 75mg.
Sodium Chloride Physiological Solution 20ml
Time frame: 0~72 hours after administration
Pain intensity will be evaluated using an 11-point (0-10) Numeric Pain Rating Scale (NPRS), with higher numbers indicating a higher pain intensity, administered over 72 hours.
Time frame: 0~72 hours after administration
Time frame: 0~72 hours after administration
Time frame: 0~24 hours after administration
Time frame: 0~24 hours,0~72 hours after administration
Time frame: 0~72 hours after administration
Time frame: 72-hours
Time frame: 72-hours
Shanghai Hengrui Pharmaceutical Co., Ltd.
Industry
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo Controlled Study to Evaluate the Efficacy and Safety of Local Administration of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659965
Acute Pain, Postoperative, Acute Post Operative Pain
Houston, Texas, United States
View Trial DetailsNCT05376904
Postsurgical Pain Management
Hefei, Anhui, China
View Trial DetailsNCT07296770
Neurologic Manifestations, Opioid Use After Surgery
San Francisco, California, United States
View Trial DetailsNCT06574269
Postsurgical Pain Management
Bellaire, Texas, United States
View Trial Details